CNTB (STOCKS)
Connect Biopharma Holdings Limited Ordinary Shares
$2.790000
-0.030000 (-1.06%)
Prev close: $2.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Barry D. Quart
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $159.96M
- Employees
- 62
- P/E (TTM)
- -2.83
- P/B (TTM)
- 3.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.91 | $-1.44 | -0.4712 | -32.66% |
|
Sep 2025 (Q3)
|
$-0.31 | $-1.01 | +0.7040 | +69.43% |
|
Jun 2025 (Q2)
|
$-0.23 | $-0.92 | +0.6892 | +74.98% |
|
Mar 2025 (Q1)
|
$-0.19 | $-1.92 | +1.7345 | +90.13% |
Financial Statements
| Revenues | $64.00K |
| Benefits Costs and Expenses | $55.35M |
| Costs And Expenses | $55.35M |
| Nonoperating Income/Loss | $2.79M |
| Operating Expenses | $58.14M |
| Research and Development | $37.80M |
| Other Operating Expenses | $20.34M |
| Operating Income/Loss | -$58.07M |
| Income/Loss From Continuing Operations After Tax | -$55.48M |
| Income/Loss From Continuing Operations Before Tax | -$55.28M |
| Income Tax Expense/Benefit | $197.00K |
| Net Income/Loss | -$55.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$55.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$55.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.00 |
| Diluted Earnings Per Share | -$1.00 |
| Basic Average Shares | 55,660,000 |
| Diluted Average Shares | 55,660,000 |
| Assets | $56.08M |
| Current Assets | $50.93M |
| Cash | $44.30M |
| Prepaid Expenses | $5.83M |
| Other Current Assets | $804.00K |
| Noncurrent Assets | $5.15M |
| Fixed Assets | $3.81M |
| Other Non-current Assets | $1.34M |
| Liabilities | $14.10M |
| Current Liabilities | $13.61M |
| Accounts Payable | $1.96M |
| Wages | $2.91M |
| Other Current Liabilities | $8.74M |
| Noncurrent Liabilities | $482.00K |
| Equity | $41.98M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $41.98M |
| Liabilities And Equity | $56.08M |
| Net Cash Flow From Operating Activities | -$51.21M |
| Net Cash Flow From Operating Activities, Continuing | -$51.21M |
| Net Cash Flow From Investing Activities | $9.82M |
| Net Cash Flow From Investing Activities, Continuing | $9.82M |
| Net Cash Flow From Financing Activities | $1.09M |
| Net Cash Flow From Financing Activities, Continuing | $1.09M |
| Exchange Gains/Losses | $408.00K |
| Net Cash Flow | -$39.89M |
| Net Cash Flow, Continuing | -$40.30M |
| Comprehensive Income/Loss | -$55.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$55.01M |
| Other Comprehensive Income/Loss | -$55.01M |